Tuesday, February 7, 2023

ActivePure Medical Joins Forces with Lighthouse Environmental Infection Prevention

ActivePure Medical LLC, the healthcare division of ActivePure Technologies LLC, announced today that Lighthouse Environmental Infection Prevention, the worldwide leader in environmental infection prevention and control, will represent the company as its acute care customer acquisition team in the United States.

Lighthouse is led by John LaRochelle, a former executive at Sodexo where he managed their global cleaning and disinfecting portfolio. Lighthouse’s team of infection prevention advisors has decades of experience finding, developing and implementing innovative solutions to reduce infection rates in healthcare systems. Lighthouse excels at developing custom solutions that improve the environment of care and they currently service more than 500 hospitals nationwide.

Lighthouse has partnered with ActivePure Medical, formerly Aerus Medical, to add continuous disinfection technology to their portfolio to address the contamination that occurs in between the routine cleaning and disinfection. ActivePure offers a range of continuous, full-facility surface and air disinfection products specifically designed for healthcare settings.

“We are excited to partner with ActivePure Medical.  Their best-in-class ActivePure Technology is an important addition to our portfolio of technologies, services, environmental testing and consulting services to stop the transmission of pathogens in healthcare facilities and reduce HAIs.  ActivePure’s FDA cleared class II medical devices, extensive clinical testing showing effectiveness, range of products and expertise assures we can create a solution for most healthcare facilities,” states Doug Manchester, Managing Partner of Lighthouse Environmental Infection Prevention.

ActivePure Medical and Lighthouse will position ozone-free, CARB certified ActivePure Guardian products made in EPA-registered establishment number 87327-VA-1 under ActivePure Manufacturing, LLC, in the hospital market. The industry-leading ActivePure Medical Guardian, an FDA cleared Class II Medical Device which received 510k status in 2020, will be among the products available.

“This opportunity provides Lighthouse improved access to our gold-standard continuous surface and air disinfection products and will enhance their comprehensive environmental infection prevention programs. ActivePure is the only brand that offers automated, proactive, and full-facility continuous surface and air disinfection that minimize pathogens and contaminants in the air and on surfaces in real-time and in areas occupied by patients and staff,” said Dan Marsh, president of ActivePure Medical. “Acute care facilities are an important channel for us, and we are very passionate about helping them in their efforts to achieve zero healthcare-associated infections (HAIs).”

All ActivePure Guardian products are designed to be effective against the most resistant pathogens found in the healthcare environment, such as MRSA, VRE, and c. Difficile spores. The ActivePure Technology has been independently tested against a broad spectrum of clinically relevant surface and airborne pathogens, including H1N1, SARS-CoV-2, Aspergillus Niger, and more. Testing can be found on file at ActivePureMedical.com. ActivePure Medical Guardian is currently undergoing a two-year, double-blind study at the Cleveland Clinic to measure effectiveness against Surgical Site Infections (SSIs). ActivePure has other real-environment case studies, including in healthcare spaces showing significant reductions in bacteria, viruses, and incidences of MRSA.

ActivePure Medical products are safe to use in spaces occupied by people, making the suite of continuous surface and air disinfection products an ideal solution for facility-wide adoption in the healthcare space. These safe and highly effective products come in both heating, ventilation and air conditioning (HVAC) induction variations and plug-and-play, installation-free portable units. The types of ActivePure Guardian units configured for medical facilities depend largely on the facility’s HVAC plans, layout, and independent needs or risks; most facilities use a combination of portable and induct units. To ensure that every healthcare facility has the ideal solution, ActivePure Medical’s team of experts will consult and review each facility’s specific infection prevention needs and propose a customized solution for the space.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.
Subscribe to Medical Device News Magazine

SIS Medical AG announces the US-launch and the first US-treatment with the Super-High-Pressure balloon – OPN NC® – with TWIN-Wall technology

The OPN NC® catheter has a unique TWIN-Wall design, invented at SIS Medical AG, providing a super high pressure resistance with a rated burst pressure of 35 atm with a very low compliance notes SIS Medical.

NeoDynamics Partners with Uniphar for US Distribution and Logistics

Uniphar Group is an international diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions - Commercial & Clinical, Product Access and Supply Chain & Retail. The Group is active in Ireland, the UK, Europe, the US and Australia.

Eyenuk Secures European Union Certification for Autonomous AI-Powered Detection of Age-Related Macular Degeneration and Glaucoma

“Achieving MDR certification is another major milestone for Eyenuk and a result of our early adaptation to the more stringent requirements of the new regulation,” said Kaushal Solanki, Chief Executive Officer and Founder of Eyenuk. “Moreover, this certification expanding our ability to market the EyeArt platform for two additional disease conditions in the EU reflects the flexibility of our AI-based platform and the depth of the clinical research conducted across the globe validating its effectiveness.”

By using this website you agree to accept Medical Device News Magazine Privacy Policy